In poultry , the product bromex due to its combination between enrofloxacin and a expectorant agent, is indicated to be used for treatment and control of respiratory infection assiociated with mycoplasma sp, pasteurella multocida, haemophillus paragalinarum, chonic respiratory disease (crd), in some infections produced by susceptible strains of staphylococcus, and also for other enrofloxacin- susceptible bacteria. Also when the situation imposes, the product could be used for treatment of intestinal infection produced by Salmonella sp, E.coli and other enrofloxacin-susceptible bacteria.